(Q34353251)

1 August 2017

title

Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival (English)

1 reference

1 August 2017

1 reference

1 reference

1 reference

12

Elizabeth M Jaffee

1 reference

1 August 2017

10

Lei Zheng

1 reference

1 August 2017

16

Patrizio Caturegli

1 reference

1 August 2017

2

Tanja D de Gruijl

1 reference

1 August 2017

9

Susan F Slovin

1 reference

1 August 2017

author name string

Alessandra De Remigis

1

1 reference

1 August 2017

Jennifer N Uram

3

1 reference

1 August 2017

Schey-Cherng Tzou

4

1 reference

1 August 2017

Shintaro Iwama

5

1 reference

1 August 2017

Monica V Talor

6

1 reference

1 August 2017

Todd D Armstrong

7

1 reference

1 August 2017

Saskia J A M Santegoets

8

1 reference

1 August 2017

Daniel A Laheru

11

1 reference

1 August 2017

Winald R Gerritsen

13

1 reference

1 August 2017

Alfons J M van den Eertwegh

14

1 reference

1 August 2017

Dung T Le

15

1 reference

1 August 2017

language of work or name

English

0 references

publication date

28 May 2014

1 reference

International Journal of Cancer

1 August 2017

published in

1 reference

1 August 2017

volume

136

1 reference

1 August 2017

issue

1

1 reference

1 August 2017

page(s)

127-137

1 reference

Evaluation of ipilimumab in combination with allogeneic pancreatic tumor cells transfected with a GM-CSF gene in previously treated pancreatic cancer

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199892

At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199892

Autoimmune thyroid disease elicited by NY-ESO-1 vaccination

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199892

Endocrine side effects induced by immune checkpoint inhibitors.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199892

T cell profiling reveals high CD4+CTLA-4 + T cell frequency as dominant predictor for survival after prostate GVAX/ipilimumab treatment

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199892

Management of immune-related adverse events and kinetics of response with ipilimumab

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199892

Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199892

Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199892

Immunotherapy for prostate cancer: biology and therapeutic approaches

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199892

CTLA-4 blockade increases antigen-specific CD8(+) T cells in prevaccinated patients with melanoma: three cases

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199892

A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199892

A 5' cytosine binding pocket in Puf3p specifies regulation of mitochondrial mRNAs

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199892

Template strand scrunching during DNA gap repair synthesis by human polymerase lambda.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199892

The incidence of autoimmune thyroid disease: a systematic review of the literature

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199892

Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockade

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199892

Expression of class II major histocompatibility complex molecules on thyrocytes does not cause spontaneous thyroiditis but mildly increases its severity after immunization

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199892

Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199892

The products of ribbon and raw are necessary for proper cell shape and cellular localization of nonmuscle myosin in Drosophila

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199892

Pancreatic disease in children and young adults: evaluation with CT.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199892

Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199892

Development and characterization of a cytokine-secreting pancreatic adenocarcinoma vaccine from primary tumors for use in clinical trials.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199892

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199892

Thyroid dysfunction as an unintended side effect of anticancer drugs.

6 July 2018

1 reference

A randomized, double-blind, placebo-controlled, phase II study comparing the tolerability and efficacy of ipilimumab administered with or without prophylactic budesonide in patients with unresectable stage III or IV melanoma

21 January 2018

1 reference

Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study

21 January 2018

1 reference

GM-CSF-secreting cancer immunotherapies: preclinical analysis of the mechanism of action

21 January 2018

1 reference

The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

21 January 2018

1 reference

MUC1-C oncoprotein functions as a direct activator of the nuclear factor-kappaB p65 transcription factor

21 January 2018

1 reference

Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library

21 January 2018

1 reference

Evidence of a new chimeric bcr/c-abl mRNA in patients with chronic myelocytic leukemia and the Philadelphia chromosome

21 January 2018

1 reference

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

The EFIS-EJI Ruggero Ceppellini Advanced School of Immunology Innate Immunity 2012: from evolution to revolution

21 January 2018

1 reference

Epitopes on thyroglobulin: a study of patients with thyroid disease

21 January 2018

1 reference

Thyroglobulin and anti-thyroglobulin assays in thyroid cancer monitoring

21 January 2018

1 reference

Concordance between thyroglobulin antibody assays.

21 January 2018

1 reference

Immunoassay of anti-thyroid autoantibodies: high analytical variability in second generation methods.

21 January 2018

1 reference

Prognostic significance of autoimmunity during treatment of melanoma with interferon.

21 January 2018

1 reference

Simultaneous quantification of different cyclodextrins and Gantrez by HPLC with evaporative light scattering detection

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199892

An in vivo evaluation of four spinal needles used for the combined spinal-epidural technique.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199892

Characterization of Thyroglobulin Epitopes in Patients with Autoimmune and Non-Autoimmune Thyroid Diseases Using Recombinant Human Monoclonal Thyroglobulin Autoantibodies

27 October 2018

1 reference

Thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: comparison of different assays and evaluation of causes of discrepancies

21 January 2018

1 reference

12 December 2020

Reversible thyroid dysfunction during treatment with GM-CSF

1 reference

12 December 2020

Regulation of the production of plasminogen activators by bone resorption enhancing and inhibiting factors in three types of osteoblast-like cells

1 reference

12 December 2020

Thyroid dysfunction associated with immunotherapy for patients with cancer

1 reference

12 December 2020

Autoimmune hypothyroidism and granulocyte-macrophage colony-stimulating factor

1 reference

12 December 2020

Hypothyroidism during immunotherapy with interleukin-2 is associated with antithyroid antibodies and response to treatment

1 reference

12 December 2020

A phase I clinical trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene for the treatment of pancreatic adenocarcinoma

1 reference

12 December 2020

Structure-activity relationships (SAR) of some tetracyclic heterocycles related to the immunosuppressive agent Brequinar Sodium

1 reference

12 December 2020

Heteroatom- and carbon-linked biphenyl analogs of Brequinar as immunosuppressive agents

1 reference

12 December 2020

Immunogenicity, Including Vitiligo, and Feasibility of Vaccination With AutologousGM-CSF–Transduced Tumor Cells in Metastatic Melanoma Patients

1 reference

12 December 2020

Identifiers

DOI

10.1002/IJC.28973

1 reference

1 August 2017

1 reference

1 August 2017

1 reference